国际口腔医学杂志 ›› 2020, Vol. 47 ›› Issue (2): 159-165.doi: 10.7518/gjkq.2020039

• 论著 • 上一篇    下一篇

口腔鳞状细胞癌中转化因子2β的表达及潜在的临床意义

郝福1,宁毅1,孙睿2(),郑晓旭3   

  1. 1. 山西医科大学口腔医学院·口腔医院 太原 030001
    2. 山西省人民医院口腔颌面外科 太原 030012
    3. 马里兰大学医学院附属医院肾内科 巴尔的摩 21201
  • 收稿日期:2019-07-05 修回日期:2019-12-10 出版日期:2020-03-01 发布日期:2020-03-12
  • 通讯作者: 孙睿
  • 作者简介:郝福,住院医师,硕士,Email: 283425020@qq.com
  • 基金资助:
    山西省自然科学基金(2011011037-2)

Expression and potential clinical significance of Transformer 2β in oral squamous cell carcinoma

Hao Fu1,Ning Yi1,Sun Rui2(),Zheng Xiaoxu3   

  1. 1. Shanxi Medical University School and Hospital of Stomatology, Taiyuan 030001, China
    2. Dept. of Oral and Maxillofacial Surgery, Shanxi Provincial People’s Hospital, Taiyuan 030012, China
    3. Dept. of Nephrology, Affiliated Hospital of Medical College, University of Maryland, Baltimore 21201, USA
  • Received:2019-07-05 Revised:2019-12-10 Online:2020-03-01 Published:2020-03-12
  • Contact: Rui Sun
  • Supported by:
    This study was supported by Program for Natural Science Foundation of Shanxi Province(2011011037-2)

摘要:

目的 探讨口腔鳞状细胞癌(OSCC)中转化因子2β(Tra2β)的表达及临床意义。方法 利用免疫组化检测64例OSCC中Tra2β蛋白的表达,并分析Tra2β蛋白表达与临床病理参数间的关系。Western blot和实时荧光聚合酶链反应(RT-PCT)检测22例OSCC肿瘤和癌旁组织中Tra2β蛋白和mRNA的表达情况。Kaplan-Meier分析Tra2β蛋白的表达对OSCC患者生存率的影响。Cox多因素生存分析Tra2β蛋白表达对OSCC患者预后的影响。结果 免疫组化检测结果表明Tra2β蛋白在OSCC中表达,并且它的阳性表达与分化程度和临床分期有关。实验结果表明,Tra2β蛋白和mRNA在OSCC中的表达趋势一致,肿瘤组织中Tra2β蛋白和mRNA的表达均高于癌旁组织。Kaplan-Meier分析表明,Tra2β蛋白高表达患者的预后较差。Cox多因素分析表明,Tra2β蛋白是OSCC患者预后评估的一个指标。结论 Tra2β可能为OSCC治疗的一个新的分子靶点。

关键词: 转化因子2β, 口腔鳞状细胞癌, 预后

Abstract:

Objective This study aimed to investigate the expression and clinical significance of Transformer 2β (Tra2β) in oral squamous cell carcinoma (OSCC). Methods Sixty-four samples of OSCC were subjected to immunohistochemistry to analyze the expression of Tra2β protein in OSCC and to explore the relationship between the expression of Tra2β protein and different clinical pathological parameters. Twenty-two pairs of fresh OSCC tissues and adjacent tissues were used to explore the expression of Tra2β mRNA and protein through real-time polymerase chain reaction and Western blot analyses. The Kaplan-Meier method was used to estimate and validate the effect of Tra2β protein on the survival rate of patients with OSCC. Cox multivariate regression was used to analyze the effect of Tra2β protein on the prognosis of patients with OSCC. Results Immunohistochemistry results revealed that Tra2β protein was expressed in OSCC, and the positive expression of Tra2β protein was significantly associated with the differentiation degree and clinical stage of OSCC. Moreover, the expression trends of Tra2β protein and mRNA were consistent, and the expression levels of Tra2β protein and mRNA in OSCC tissues were higher than those in adjacent tissues. Kaplan-Meier survival analysis showed that patients with OSCC and Tra2β protein expression had poor prognoses. Cox multivariate regression analysis demonstrated that the Tra2β protein was an independent prognostic factor of OSCC. Conclusion Tra2β may be a new molecular target for the treatment of OSCC.

Key words: Transformer 2β, oral squamous cell carcinoma, prognosis

中图分类号: 

  • R739.81

表 1

RT-PCR引物序列及产物长度"

基因 引物(5’~3’) 产物长度/bp
Tra2β 正向引物:TGCGGAGGCGGTGCGGAGCATT;反向引物:CATGACTCCTGGCTGCTGTCGCC 149
GADPH 正向引物:CAACAGCCTCAAGATCATCAGC;反向引物:CATGAGTCCTTCCACGATACCA 103
临床病理参数 阴性(-) 弱阳性(+) 中阳性(++) 强阳性(+++) P
年龄/岁 >60 3 18 13 2 0.341
≤60 0 15 9 4
性别 1 16 10 5 0.443
2 17 12 1
淋巴结转移 0 3 7 1 0.162
3 30 15 5
病变部位 1 10 5 0 0.235
0 2 3 1
0 3 4 1
牙龈 1 17 7 2
1 1 3 2
临床分期 T1 1 18 5 2 <0.001*
T2 1 6 6 2
T3 1 6 6 0
T4 0 3 5 2
分化程度 高分化 1 26 3 1 0.046*
中分化 1 6 18 3
低分化 1 1 1 2

图 1

Tra2β蛋白在OSCC中表达的免疫组化染色 A:阴性对照 × 100;B:弱阳性表达 × 200;C:中阳性表达 × 200;D:强阳性表达 × 200。"

表 2

Tra2β蛋白表达与64例OSCC临床病理参数的关系"

图 2

Tra2β蛋白在OSCC肿瘤和癌旁组织中的表达 A:Tra2β蛋白在8例OSCC患者肿瘤和癌旁组织中的表达;B:Tra2β蛋白在Hela细胞中的表达;C:Tra2β蛋白在22例OSCC肿瘤和癌旁组织中的相对表达量。*示P<0.05,差异有统计学意义。"

图 3

Tra2β mRNA在22例OSCC肿瘤和癌旁组织中的相对表达量 注:*示P<0.05,差异有统计学意义。"

图 4

Tra2β蛋白表达对OSCC患者生存率的影响"

[1] Chi AC, Day TA, Neville BW . Oral cavity and oro-pharyngeal squamous cell carcinoma: an update[J]. CA Cancer J Clin, 2015,65(5):401-421.
[2] Bray F, Ferlay J, Soerjomataram I , et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 coun-tries[J]. CA Cancer J Clin, 2018,68(6):394-424.
[3] de Camargo Cancela M, de Souza DL, Curado MP . International incidence of oropharyngeal cancer: a population-based study[J]. Oral Oncol, 2012,48(6):484-490.
[4] Siegel R, Naishadham D, Jemal A . Cancer statistics, 2013[J]. CA Cancer J Clin, 2013,63(1):11-30.
[5] Elliott DJ, Best A, Dalgliesh C , et al. How does Tra2β protein regulate tissue-specific RNA splicing[J]. Biochem Soc Trans, 2012,40(4):784-788.
[6] Liu J, Bian TT, Feng J , et al. miR-335 inhibited cell proliferation of lung cancer cells by target Tra2β[J]. Cancer Sci, 2018,109(2):289-296.
[7] Harding BN, Kariya S, Monani UR , et al. Spectrum of neuropathophysiology in spinal muscular atrophy typeⅠ[J]. J Neuropathol Exp Neurol, 2015,74(1):15-24.
[8] Roberts JM, Ennajdaoui H, Edmondson C , et al. Splicing factor TRA2B is required for neural pro-genitor survivaⅠ[J]. J Comp Neurol, 2014,522(2):372-392.
[9] Mende Y, Jakubik M, Riessland M , et al. Deficiency of the splicing factor Sfrs10 results in early embr-yonic lethality in mice and has no impact on full-length SMN/Smn splicing[J]. Hum Mol Genet, 2010,19(11):2154-2167.
[10] Best A, Dagliesh C, Ehrmann I , et al. Expression of Tra2 β in cancer cells as a potential contributory factor to neoplasia and metastasis[J]. Int J Cell Biol, 2013,2013:843781.
[11] Yang LX, Tao T, Wang YF , et al. Knocking down the expression of TRA2β inhibits the proliferation and migration of human glioma cells[J]. Pathol Res Pract, 2015,211(10):731-739.
[12] Kajita K, Kuwano Y, Kitamura N , et al. Ets1 and heat shock factor 1 regulate transcription of the Tran-sformer 2β gene in human colon cancer cells[J]. J Gastroenterol, 2013,48(11):1222-1233.
[13] Diao Y, Wu D, Dai Z , et al. Prognostic value of transformer 2β expression in prostate cancer[J]. Int J Clin Exp Pathol, 2015,8(6):6967-6973.
[14] Ji LL, Ni TT, Shen YB , et al. Transformer 2β (Tra2β/SFRS10) positively regulates the progression of NSCLC via promoting cell proliferation[J]. J Mol Hist, 2014,45(5):573-582.
[15] Kajita K, Kuwano Y, Satake Y , et al. Ultraconserved region-containing Transformer 2β4 controls senes-cence of colon cancer cells[J]. Oncogenesis, 2016,5:e213.
[16] Ghosh P, Grellscheid SN, Sowdhamini R . A tale of two paralogs: human Transformer2 proteins with differential RNA-binding affinities[J]. J Biomol Struct Dyn, 2016,34(9):1979-1986.
[17] Bonnal S, Vigevani L, Valcárcel J . The spliceosome as a target of novel antitumour drugs[J]. Nat Rev Drug Discov, 2012,11(11):847-859.
[18] Anderson ES, Lin CH, Xiao XS , et al. The cardio-tonic steroid digitoxin regulates alternative splicing through depletion of the splicing factors SRSF3 and TRA2B[J]. RNA, 2012,18(5):1041-1049.
[19] Venables JP, Elliott DJ, Makarova OV , et al. RBMY, a probable human spermatogenesis factor, and other hnRNP G proteins interact with Tra2beta and affect splicing[J]. Hum Mol Genet, 2000,9(5):685-694.
[20] Kuwano Y, Nishida K, Kajita K , et al. Transformer 2β and miR-204 regulate apoptosis through compe-titive binding to 3’ UTR of BCL2 mRNA[J]. Cell Death Differ, 2015,22(5):815-825.
[21] Backes C, Kehl T, Stöckel D , et al. miRPathDB: a new dictionary on microRNAs and target pathways[J]. Nucleic Acids Res, 2017,45(D1):D90-D96.
[22] Troiano G, Mastrangelo F, Caponio VCA , et al. Pre-dictive prognostic value of tissue-based MicroRNA expression in oral squamous cell carcinoma: a sys-tematic review and meta-analysis[J]. J Dent Res, 2018,97(7):759-766.
[23] Eckert AW, Wickenhauser C, Salins PC , et al. Clinical relevance of the tumor microenvironment and im-mune escape of oral squamous cell carcinoma[J]. J Transl Med, 2016,14:85.
[24] Momen-Heravi F, Bala S . Emerging role of non-coding RNA in oral cancer[J]. Cell Signal, 2018,42:134-143.
[25] Malik UU, Zarina S, Pennington SR . Oral squamous cell carcinoma: key clinical questions, biomarker discovery, and the role of proteomics[J]. Arch Oral Biol, 2016,63:53-65.
[26] Ho JJ, Marsden PA . Competition and collaboration between RNA-binding proteins and microRNAs[J]. Wiley Interdiscip Rev RNA, 2014,5(1):69-86.
[1] 周金阔,张晋弘,史晓晶,刘广顺,姜磊,刘倩峰. 长链非编码RNA小核仁RNA宿主基因22调控微小RNA-27b-3p对口腔鳞状细胞癌细胞增殖、侵袭和迁移的影响[J]. 国际口腔医学杂志, 2024, 51(1): 52-59.
[2] 李立恒,王蕊,王晓明,张智轶,张璇,安峰,王芹,张凡. 环状RNA hsa_circ_0085576调控微小RNA-498/B细胞特异性莫洛尼鼠白血病病毒整合位点1轴对口腔鳞状细胞癌细胞迁移和侵袭的影响[J]. 国际口腔医学杂志, 2024, 51(1): 60-67.
[3] 吴佳敏,夏斌,杨禾丰,许彪. 癌相关成纤维细胞在口腔鳞状细胞癌微环境中作用的研究进展[J]. 国际口腔医学杂志, 2023, 50(6): 711-717.
[4] 柳江龙, 买买提吐逊·吐尔地. 超声造影在口腔鳞状细胞癌颈部转移性淋巴结诊断中的研究进展[J]. 国际口腔医学杂志, 2023, 50(5): 514-520.
[5] 盛南宁,王珏,南欣荣. 性别决定基因盒9在口腔鳞状细胞癌作用机制和治疗中的研究进展[J]. 国际口腔医学杂志, 2023, 50(3): 314-320.
[6] 李潭,梁新华. 盘状蛋白结构域受体1在调控恶性肿瘤进展和治疗中的作用[J]. 国际口腔医学杂志, 2023, 50(2): 230-236.
[7] 赵卓平,辛鹏飞,高阳,张彩凤,张宽收,刘青梅. 光热治疗在口腔鳞状细胞癌治疗中的研究进展[J]. 国际口腔医学杂志, 2022, 49(4): 462-470.
[8] 江涵,神应强,陈谦明. 毒蕈碱受体通过Yes相关蛋白信号对口腔鳞状细胞癌生物学行为的实验研究[J]. 国际口腔医学杂志, 2022, 49(2): 138-143.
[9] 白皓亮,杨禾,赵蕾. 牙周病风险评估及预后判断工具的研究进展[J]. 国际口腔医学杂志, 2021, 48(6): 696-702.
[10] 蒋宇磊,夏斌,饶南荃,杨禾丰,许彪. 外泌体在口腔鳞状细胞癌恶性进展及诊疗应用的研究[J]. 国际口腔医学杂志, 2021, 48(6): 711-717.
[11] 马平川,李春洁,李龙江. 唾液腺导管癌的诊疗研究进展[J]. 国际口腔医学杂志, 2021, 48(4): 459-467.
[12] 甘建国,高攀,王晓毅. 循环肿瘤细胞与口腔鳞状细胞癌相关性的研究进展[J]. 国际口腔医学杂志, 2021, 48(2): 205-212.
[13] 黄俊文,乔洁,梅子,陈茁,李杨,乔彬. 脂多糖结合蛋白在口腔鳞状细胞癌中的表达及其临床意义[J]. 国际口腔医学杂志, 2021, 48(1): 50-57.
[14] 何宇晴,但红霞,陈谦明. 光动力疗法在口腔黏膜癌变防治中的应用[J]. 国际口腔医学杂志, 2020, 47(6): 669-676.
[15] 薛伶俐,李雅冬. 经首次根治性手术治疗口腔鳞状细胞癌患者的生存相关影响因素分析[J]. 国际口腔医学杂志, 2020, 47(2): 166-174.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 张新春. 桩冠修复与无髓牙的保护[J]. 国际口腔医学杂志, 1999, 26(06): .
[2] 王昆润. 长期单侧鼻呼吸对头颅发育有不利影响[J]. 国际口腔医学杂志, 1999, 26(05): .
[3] 彭国光. 颈淋巴清扫术中颈交感神经干的解剖变异[J]. 国际口腔医学杂志, 1999, 26(05): .
[4] 杨凯. 淋巴化疗的药物运载系统及其应用现状[J]. 国际口腔医学杂志, 1999, 26(05): .
[5] 康非吾. 种植义齿下部结构生物力学研究进展[J]. 国际口腔医学杂志, 1999, 26(05): .
[6] 柴枫. 可摘局部义齿用Co-Cr合金的激光焊接[J]. 国际口腔医学杂志, 1999, 26(04): .
[7] 孟姝,吴亚菲,杨禾. 伴放线放线杆菌产生的细胞致死膨胀毒素及其与牙周病的关系[J]. 国际口腔医学杂志, 2005, 32(06): 458 -460 .
[8] 费晓露,丁一,徐屹. 牙周可疑致病菌对口腔黏膜上皮的粘附和侵入[J]. 国际口腔医学杂志, 2005, 32(06): 452 -454 .
[9] 赵兴福,黄晓晶. 变形链球菌蛋白组学研究进展[J]. 国际口腔医学杂志, 2008, 35(S1): .
[10] 庞莉苹,姚江武. 抛光和上釉对陶瓷表面粗糙度、挠曲强度及磨损性能的影响[J]. 国际口腔医学杂志, 2008, 35(S1): .